Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/PTX stock hub

ASX/PTX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/PTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

56.8M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/PTX

In the news

Latest news · ASX/PTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-54.3

P25 -118.7P50 -49.4P75 -1.2

ROIC-33.8

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/PTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

AUD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	3
Enterprise value	AUD 47.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000PTX3
Last refreshed	2026-05-10
Market cap	AUD 56.8M
Price	AUD 0.05
Price currency	AUD
Rev Per Employee	1,421,915.67x
Sector	Healthcare
Sic	2836
Symbol	asx/PTX
Website	https://ptxtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.6%
EV Earnings	-5.34x
EV/Sales	11.09x
P/B ratio	3.35x
P/S ratio	13.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-208.79%
Gross margin	100%
Gross Profit	AUD 4.3M
Gross Profit Growth	-2.08%
Gross Profit Growth Q	-7.26%
Gross Profit Growth3 Y	4.74%
Gross Profit Growth5 Y	11.93%
Net Income	AUD -8.9M
Net Income Growth Years	1%
Pretax Margin	-207.71%
Profit Margin	-207.71%
Profit Per Employee	AUD -3M
ROA	-31.75
Roa5y	-19.76
ROCE	-51.77
ROE	-54.33
Roe5y	-34.7
ROIC	-33.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.46%
Cagr15y	-26.08%
Cagr1y	12.51%
Cagr20y	-25.33%
Cagr3y	-17.73%
Cagr5y	-9.51%
EPS Growth Years	1
Revenue Growth	41.2x
Revenue Growth Q	-7.26x
Revenue Growth Years	5x
Revenue Growth3 Y	4.74x
Revenue Growth5 Y	11.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.24
Assets	AUD 18.5M
Cash	AUD 9.8M
Current Assets	AUD 16.6M
Current Liabilities	AUD 1.3M
Debt	AUD 272,915
Debt Equity	AUD 0.02
Equity	AUD 17M
Liabilities	AUD 1.5M
Long Term Assets	AUD 1.9M
Long Term Liabilities	AUD 231,146
Net Cash	AUD 9.5M
Net Cash By Market Cap	AUD 16.72
Net Cash Growth	13.42%
Net Debt Equity	AUD -0.56
Tangible Book Value	AUD 15.3M
Tangible Book Value Per Share	AUD 0.01
WACC	6.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.95
Net Working Capital	AUD 5.6M
Quick ratio	12.1
Working Capital	AUD 15.3M
Working Capital Turnover	AUD 0.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.27%
Dividend per share	AUD 0
Last Dividend	AUD 19.66

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-48.73%
1Y total return	12.5%
200-day SMA	0.06
3Y total return	-44.33%
50-day SMA	0.06
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.33%
All Time High	396.5
All Time High Change	-99.99%
All Time High Date	1993-11-04
All Time Low	0.02
All Time Low Change	145.45%
All Time Low Date	2020-03-24
ATR	0
Beta	0.41
Beta1y	0.7
Beta2y	0.85
Ch YTD	-35.71
High	0.05
High52	0.13
High52 Date	2025-12-17
High52ch	-56.8%
Low	0.05
Low52	0.04
Low52 Date	2025-09-15
Low52ch	35%
Ma50ch	-2.17%
Price vs 200-day SMA	-6.9%
RSI	50.39
RSI Monthly	46.98
RSI Weekly	43.46
Sharpe ratio	0.42x
Sortino ratio	0.79
Total Return	-12.27%
Tr YTD	-35.71
Tr15y	-98.93%
Tr1m	5.88%
Tr3m	-19.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -8.9M
Operating margin	-208.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	928,970,609%
Net Borrowing	187,148
Shares Insiders	9.5%
Shares Institutions	1.05%
Shares Out	1,051,514,543
Shares Qo Q	24.55%
Shares Yo Y	12.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	886,479.6x
Bv Per Share	0.02
Ch10y	-50.91
Ch15y	-99
Ch1m	5.88
Ch1y	12.5
Ch20y	-99.73
Ch3m	-19.4
Ch3y	-44.33
Ch5y	-39.33
Ch6m	20
Change	1.89%
Change From Open	1.89
Close	0.05
Days Gap	0
Depreciation Amortization	-5,296
Dollar Volume	4,676
Earnings Date	2026-05-25
EBIT	AUD -8.9M
EPS	AUD -0.01
F Score	2
Financing CF	9,351,784
Fiscal Year End	June
Founded	1,986
Investing CF	2,000,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2014-12-02
Last Split Type	Reverse
Ma150	0.06
Ma150ch	-14.56%
Ma20	0.05
Ma20ch	2.08%
Net CF	3,362,313
Next Earnings Date	2026-05-25
Open	0.05
Position In Range	100
Ppne	274,073
Price Date	2026-05-08
Ptbv Ratio	3.71
Relative Volume	0.1x
Revenue	4,265,747x
SBC By Revenue	8.18x
Share Based Comp	349,011
Tr20y	-99.71%
Tr6m	20%
Volume	86,593
Z Score	11.16

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/PTX pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/PTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/PTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.0%

Share of float held by funds and institutions

Insider ownership

+9.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+12.3%

Negative means the company is buying back shares.

Technical

ASX/PTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.4

Neutral momentum band

Price vs 200-day MA

-6.9%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/PTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/PTX stock rating?

asx/PTX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/PTX analysis?

The full report lives at /stocks/asx/PTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/PTX?

The latest report frames asx/PTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/PTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.